Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “air” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 160
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 160 pipeline programs matching "air" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

160 results for “air” Back to intelligence hub

Search results

Page 7 of 7
  1. Dental foam "Biorepair PERIBIOMA"

    The First People's Hospital of Lianyungang

    Oral Health

    approved small molecule completed

    1 trial
  2. Fill out Questionnaire

    Rhythm Pharmaceuticals Netherlands B.V.

    Bradycardia

    approved other completed

    1 trial
  3. Gabapentin

    United Therapeutics Europe Ltd

    Peripheral Nerve Disorder Associated With Repair of Hernia

    approved small molecule active

    1 trial
  4. MIYAIRI 588

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depression Mild

    approved small molecule completed

    1 trial
  5. NL65364.078.18

    Disc Medicine

    Strictures after esophageal atresia repair

    approved small molecule active

    1 trial
  6. SPD489

    Takeda

    ADHD Specifically With Executive Function Impairment

    approved small molecule completed

    1 trial
  7. Tiotropium 'Respimat' 5 mcg

    Universal Integrated

    Chronic Obstructive Airway Disease

    approved small molecule active

    1 trial
  8. Xolair

    United Therapeutics Europe Ltd

    Atopic Eczema

    approved small molecule completed

    1 trial
  9. Xolair 75 mg solution for injection in pre-filled syringe

    Pari Pharma GmbH

    Well controlled severe allergic asthma

    approved small molecule active

    1 trial
  10. Bufei Recipe

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Preserved Ratio Impaired Spirometry

    small molecule active

    1 trial
  11. Dairy based toddler nutrition

    United Therapeutics Europe Ltd

    Weight Gain

    other active

    1 trial
  12. Influence of propofol sedation on memory consolidation and 'working memory'

    The First People's Hospital of Lianyungang

    Memory Impairment

    small molecule completed

    1 trial
  13. Miyarisan-BM (Clostridium Butyricum Miyairi)

    Hospital Authority, Hong Kong

    Clostridium Butyricum Miyairi

    small molecule active

    1 trial
  14. Nutra 1-0602

    Harmony Biosciences Holdings

    Hair Thinning

    other completed

    1 trial
  15. Nutra 2-1216

    Harmony Biosciences Holdings

    Hair Thinning

    other active

    1 trial
  16. mitomycin C

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obstructive Airway Disease

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.